Here’s what you need to know:
1. Study participants have chronic cervical injuries involving C5-C7 vertebrae.
2. Researchers seek to understand the safety and toxicity associated with an FDA-approved line of human stem cells.
3. The six stem cell injections’ impact on chronic traumatic spinal injuries will be monitored during a follow-up period of 60 months.
4. The stem cells were previously tested in patients with amyotrophic lateral sclerosis.
5. Principal investigator Joseph Ciacci, MD, of UC San Diego said, “The ultimate goal is development of an effective treatment for paralyzing spinal cord injuries…The immediate goal is to determine whether injecting these neural stem cells into the spines of patients with injuries is safe.”
More articles on spine:
Lateral Approaches to Spine Surgery – Decisions and Challenges
Mayo uses epidural stimulation to help spinal cord injury patients move: 5 things to know
9 spine surgeons & neurosurgeons on the move in March 2017
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.